|
Gorog DA, Gue YX, Chao TF, Fauchier L, Ferreiro JL, Huber K, Konstantinidis SV, Lane DA, Marin F, Oldgren J, Potpara T, Roldan V, Rubboli A, Sibbing D, Tse HF, Vilahur G, Lip GYH. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. Europace. 2022 Nov 22;24(11):1844-1871. doi: 10.1093/europace/euac020. PubMed PMID: 35323922.
AÑO: 2022; IF: 6.1
|
35323922
|
Ding WY, Rivera-Caravaca JM, Marin F, Li G, Roldan V, Lip GYH. Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence. Br J Clin Pharmacol. 2022 Jan;88(1):282-289. doi: 10.1111/bcp.14961. Epub 2021 Jul 13. PubMed PMID: 34192808.
AÑO: 2022; IF: 3.4
|
|
Roldan V, Martinez-Montesinos L, Lopez-Galvez R, Garcia-Tomas L, Lip GYH, Rivera-Caravaca JM, Marin F. Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists. J Pers Med. 2022 Mar 17;12(3):487. doi: 10.3390/jpm12030487. PubMed PMID: 35330486; PubMed Central PMCID: PMC8954236.
AÑO: 2022; IF: 3.508
|
|
Ding WY, Rivera-Caravaca JM, Marin F, Roldan V, Lip GYH. Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial. J Thromb Thrombolysis. 2022 Jul;54(1):1-6. doi: 10.1007/s11239-022-02638-0. Epub 2022 Apr 15. PubMed PMID: 35426602; PubMed Central PMCID: PMC9259516.
AÑO: 2022; IF: 4.0
|
|
Lopez-Galvez R, Roldan V, Marin F. Diagnostic and therapeutic potential of miRNAs in cardiovascular disease: a clinical reality? Rev Esp Cardiol (Engl Ed). 2022 Sep;75(9):704-705. doi: 10.1016/j.rec.2022.02.008. Epub 2022 Apr 20. No abstract available. English, Spanish. PubMed PMID: 35461793.
AÑO: 2022; IF: 6.975
|